U.S. FDA approves Eli Lilly's Basaglar diabetes drug

(Reuters) - The U.S. Food and Drug Administration on Wednesday approved Eli Lilly & Co's diabetes drug Basaglar, a cheaper version of Sanofi AG's top-selling drug Lantus.

http://ift.tt/xePdMM

from Reuters: Health News
via animenewspro